Prenetics Global’s continuing-operations Revenue moved from $15.936 million in 2024 to $92.390 million in 2025, with Consumer Health contributing $79.445 million. The 2026 outlook calls for Marketing expense of 45% to 50% of revenue, alongside broader platform distribution and continued subscription and pricing changes.

Key Highlights

  • Consumer Health generated $79.445 million, representing 86% of continuing-operations revenue.
  • Prevention revenue reached $12.945 million, accounting for the remaining 14%.
  • About 80% of new IM8 orders came through monthly or quarterly subscriptions as of December 31, 2025.

Revenue Concentrated In Consumer Health

Consumer Health accounted for $79.445 million of the total, while Prevention contributed $12.945 million. Consumer Health represented 86% of continuing-operations revenue in 2025, compared with 14% for Prevention. Prevention revenue increased from $10.367 million in 2024 to $12.945 million, while Consumer Health revenue stood at $79.445 million versus $5.569 million in 2024. Revenue from Hong Kong was $23.070 million, compared with $10.425 million in 2024. The United States contributed $69.320 million, versus $5.511 million in 2024.

Gross Profit Reached $48.790M

Revenue from continuing operations was accompanied by $43.600 million in direct costs, resulting in Gross Profit of $48.790 million. IM8 revenue was subscription-led. Approximately 80% of new IM8 orders were placed through monthly or quarterly subscription plans as of December 31, 2025. Prenetics Global Ltd (NASDAQ: PRE) also said it began moving a growing portion of new customers from monthly to quarterly plans in late 2025 and early 2026. The company intends to continue adjusting subscription mix and pricing. The Diagnostics Business was disposed of on October 1, 2025, and is presented as discontinued operations. The continuing-operations figures therefore reflect the Prevention and Consumer Health segments.

Marketing Expansion Planned For 2026

Paid spending was concentrated on Meta platforms as of March 31, 2026, with approximately 80% deployed there and 15% on Google. The 2026 plan includes Diversification into YouTube, TikTok and AppLovin. Management also plans to keep refining subscription structure and pricing, with the stated aim of improving unit Economics and long-term revenue visibility.

Subscriber Retention Remains A Risk

Subscriber conversion and retention are identified as key factors affecting revenue and profitability. Shifts in consumer preferences, competitive alternatives and macroeconomic conditions could affect willingness to maintain discretionary health-related subscriptions. Customer Acquisition costs could increase without corresponding improvements in customer quality or retention. The company also identifies reliance on suppliers, manufacturers, distributors and service providers as a risk, alongside platform concentration. These factors sit alongside the planned expansion across YouTube, TikTok and AppLovin.